lirlife.comCrawled Nov 19, 2026
The common shares of LIR Life Sciences Corp., previously listed as Blackbird Critical Metals Corp., have been approved for listing on the Canadian Securities Exchange.
Vancouver, Canada – December 10, 2025 – Lir Life Sciences Corp. (CSE: SKNY) (Frankfurt: N790, WKN: A41QA9) (“Lir” or the “Company”) is pleased to announce the design of a new comparative cell-penetrating peptide-based uptake study (the “Study”) of GLP/GIP[1]-based obesity therapies, further advancing its novel transdermal platform for obesity and metabolic disease. This initiative is intended to further the Company’s research and development of patient-friendly, needle-free delivery options for
Vancouver, Canada – November 10, 2025 – Lir Life Sciences Corp. (CSE: SKNY) (formerly Blackbird Critical Metals Corp.) (“Lir Life Sciences” or the “Company“) is pleased to announce, further to its news release dated August 14, 2025, that it has completed the acquisition (the “Transaction”) of all of the issued and outstanding shares of Lir Life Sciences Inc. (“Lir Inc.”), and that trading in the common shares of the Company resumed on the Canadian Securities Exchange (the “CSE”) on November 7, 2
LIR Life Sciences filed a provisional patent for a needle-free delivery system for GLP/GIP-based therapies in obesity and metabolic disease.
LIR Life Sciences develops GLP-1 therapies using drug-delivery approaches to improve accessibility, effectiveness, and affordability.
LIR Life Sciences advances obesity treatment through transdermal and alternative delivery methods for GLP-1 therapies, aiming to reduce injection reliance.
Advancing obesity treatment with an exclusive novel platform delivery system, a holistic and innovative approach to drug delivery.
The information provided on this website (https://lirlife.com) is for informational purposes only and should not be considered an offer, solicitation, or recommendation to buy or sell securities or other financial products of Lir Life Sciences Inc. (“Lir Life Sciences” or the “Company”), a publicly traded company.